Mode
Text Size
Log in / Sign up

Normal-tension glaucoma

Part of Glaucoma

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for normal-tension glaucoma

5 trials tracked for normal-tension glaucoma: 2 in phase 3 or 4.

5Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 2 Other / NA 3
  1. Phase 4 Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Completed
  2. Phase 4 Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma Completed
  3. N/A Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma Completed
  4. N/A Systemic Glutathione Level in Normal Tension Glaucoma Completed
  5. N/A Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Glaucoma

Related studies from across the Glaucoma family.

Metformin use linked to modest glaucoma risk reduction in diabetic patients
Ophthalmology Meta-analysis
Metformin use linked to modest glaucoma risk reduction in diabetic patients Metformin use linked to lower glaucoma risk in people with diabetes
A large meta-analysis of diabetic patients found metformin use associated with a modest reduction in glaucoma incidence, though evidence cer…
A massive review of over 1.2 million patients suggests metformin might lower the chance of developing glaucoma compared to other diabetes dr…
Netarsudil plus latanoprost cuts diurnal IOP 2.36 mmHg vs latanoprost alone in Japanese glaucoma
Ophthalmology RCT
Netarsudil plus latanoprost cuts diurnal IOP 2.36 mmHg vs latanoprost alone in Japanese glaucoma Adding netarsudil to latanoprost lowers eye pressure faster in Japanese patients with glaucoma
This Phase III randomized controlled trial in 246 Japanese participants with primary open-angle glaucoma or ocular hypertension found that n…
Japanese patients with glaucoma saw lower eye pressure when adding netarsudil to their current latanoprost drops compared to a placebo plus …
Integrated care combining antiangiogenic bridging and ischemia-directed therapies supports long-term success in neovascular glaucoma management
Rheumatology Sys. Review
Integrated care combining antiangiogenic bridging and ischemia-directed therapies supports long-term success in neovascular glaucoma management Integrated care offers long-term success for neovascular glaucoma
This narrative review addresses neovascular glaucoma management in patients with retinal ischemia. The authors argue that long-term success …
A review suggests combining antiangiogenic bridging with ischemia management and surgery may help patients with neovascular glaucoma achieve…
Review of glaucoma management without reported intervention details or outcomes
Neurology Sys. Review
Review of glaucoma management without reported intervention details or outcomes Review finds no clear best treatment for glaucoma
This narrative review addresses glaucoma management but does not report specific interventions, comparators, or outcomes. The authors provid…
A review of glaucoma treatments found no single approach is clearly best. What this means for patients.
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues
Ophthalmology Meta-analysis
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues New data shows netarsudil offers a safer option for some glaucoma patients
A Bayesian network meta-analysis found netarsudil ranked lower for IOP reduction but had a more favorable conjunctival hyperemia profile com…
A fresh look at glaucoma drugs shows one option causes less redness while still helping lower eye pressure effectively.
Meta-analysis of tafluprost-timolol fixed-dose combination for open-angle glaucoma and ocular hypertension
Ophthalmology Meta-analysis
Meta-analysis of tafluprost-timolol fixed-dose combination for open-angle glaucoma and ocular hypertension Tafluprost-timolol drops lower eye pressure than switching to single drugs
This meta-analysis evaluated the tafluprost-timolol fixed-dose combination versus a monotherapy switch group in patients with open-angle gla…
A meta-analysis of 2066 patients found that fixed-dose tafluprost-timolol lowered eye pressure more than switching to monotherapy, with mini…
Motivational Interviewing Workshop Improves Communication Skills in Ophthalmology Residents
Ophthalmology RCT
Motivational Interviewing Workshop Improves Communication Skills in Ophthalmology Residents Motivational Interviewing Workshop Boosts Glaucoma Counseling Skills
This pilot RCT with 20 ophthalmology residents found that a 1-hour Motivational Interviewing workshop improved standardized patient encounte…
A simple one-hour class helps doctors talk to glaucoma patients in ways that actually change behavior and improve medication use.
Perioperative taVNS Reduces Pain and Insomnia After Glaucoma Surgery
Ophthalmology RCT
Perioperative taVNS Reduces Pain and Insomnia After Glaucoma Surgery Vagus nerve stimulation lowers pain after glaucoma surgery
This randomized trial of 94 patients undergoing glaucoma surgery found that perioperative transcutaneous auricular vagus nerve stimulation (…
A trial found that vagus nerve stimulation reduced pain and improved sleep for patients having glaucoma surgery under general anesthesia.
Retrospective review links higher TAPE score to better SLT outcomes in glaucoma
Ophthalmology
Retrospective review links higher TAPE score to better SLT outcomes in glaucoma New laser settings help lower eye pressure for years without extra drops
This retrospective review of 62 eyes undergoing lower-energy SLT found that higher TAPE scores were associated with lower IOP at 2 months an…
A new way to tune laser energy for glaucoma could keep pressure low for years while avoiding the need for daily eye drops.
Micropulse transscleral cyclophotocoagulation showed less pain and inflammation than continuous-wave in refractory glaucoma patients
Ophthalmology RCT
Micropulse transscleral cyclophotocoagulation showed less pain and inflammation than continuous-wave in refractory glaucoma patients New laser option for hard-to-treat glaucoma cuts pain and swelling
This prospective, randomized, single-blind study enrolled 52 patients with refractory glaucoma.
A gentler laser lowers eye pressure as well as older methods but causes less pain and swelling.
Review of portable visual field devices shows higher patient preference over table-mounted analyzers in rural glaucoma care
Ophthalmology
Review of portable visual field devices shows higher patient preference over table-mounted analyzers in rural glaucoma care Portable eye tests beat old machines for rural patients
This mixed methods review analyzed patient preferences among 271 respondents at three Alabama Federally Qualified Health Centers.
Rural patients with glaucoma preferred portable virtual reality eye tests over traditional machines, reporting higher satisfaction and comfo…
Polygenic risk score enrichment reduces sample size needs for coronary artery disease and inflammatory bowel disease trials
Genetics & Precision Medicine Cohort
Polygenic risk score enrichment reduces sample size needs for coronary artery disease and inflammatory bowel disease trials Smarter trial designs could cut study sizes by 60% for heart disease
This in silico observational cohort study used UK Biobank data to model trial designs enriched for polygenic risk.
Using genetic risk scores to pick high-risk volunteers could shrink trial sizes by 60% for heart disease and 78% for IBD, speeding up resear…